RA Capital Management
About RA Capital Management
RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Investment focus
Stages
Sectors
Portfolio (26 in our database)
SomatusSomatus is a healthcare company that partners with health plans, health systems, nephrology, and primary care groups.Series E · $465M raisedElement BiosciencesElement Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets.Series C · $401M raisedExoExo is a medical device startup which develops handheld ultrasound devices and AI for imaging and therapeutic applications.Series C · $308M raisedViaCyteViaCyte is a preclinical therapeutic company specializing in regenerative medicine therapies for diabetes.Series D · $236M raisedAntios TherapeuticsAntios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.Series B · $200M raisedArtiva BiotherapeuticsArtiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.Series B · $198M raisedSynthekineSynthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.Series B · $190M raisedBe BiopharmaBe Biopharma is developing B ceaBe Biopharma is a biotech research company that develops a class of B cells as medicines.lls as medicines.Series B · $182M raisedGentiBioGentiBio is a biotherapeutics company developing engineered regulatory T cells programmed to treat autoimmune allergic diseases.Series A · $177M raisedPlexiumPlexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.Series B · $165M raisedObsidian TherapeuticsObsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.Series B · $165M raisedAsher BioAsher Bio is a biotechnology company that specializes in the fields of therapeutics builds better immunotherapy for cancer.Series B · $163M raisedMineralys TherapeuticsMineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.Series B · $162M raisedLocanabioLocana develops RNA-targeting gene therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.Series B · $156M raisedFrontier MedicinesFrontier Medicines is a developer of a chemoproteomics platform intended to further accelerate the path to drug discovery.Series B · $156M raisedBoundless BioBoundless Bio is a precision oncology company developing therapeutics directed against extrachromosomal DNA (ecDNA) in aggressive cancers.Series B · $151M raisedCedilla TherapeuticsCedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.Series B · $139M raisedTassoTasso is a Medical innovation company changing the way diagnostics are deliveredSeries B · $136M raisedCeribellCeribell focuses on making electroencephalography (EEG) widely accessible, more efficient, and more cost-effective.Series C · $121M raisedScribe TherapeuticsScribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.Series B · $120M raisedAcrivon TherapeuticsAcrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.Series B · $116M raisedDTx PharmaDTx Pharma is developing technology that will unleash RNA-based therapeutics as the modality of choice.Series B · $114M raisedSionna TherapeuticsSionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).Series B · $110M raisedElectra TherapeuticsElectra Therapeutics is a clinical stage biotechnology company developing therapies for cancer and other immunological diseases.Series B · $100M raisedJnana TherapeuticsJnana Therapeutics is a biotechnology company developing therapies that transform the lives of patients.Series B · $100M raisedCurie TherapeuticsCurie Therapeutics is a fully integrated next-generation radiopharmaceutical firm that combines ligand research and radiochemistry experts.Series A · $75M raised